This topic contains a solution. Click here to go to the answer

Author Question: CT is not the best modality to demonstrate pathology for which organ? A) liver B) spleen C) ... (Read 72 times)

Cooldude101

  • Hero Member
  • *****
  • Posts: 557
CT is not the best modality to demonstrate pathology for which organ?
 A) liver
  B) spleen
  C) pancreas
  D) gallbladder

Question 2

The inferior vena cava (IVC) is in theA) peritoneal cavity.
  B) anterior pararenal space.
  C) perirenal space.
  D) posterior pararenal space.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

InfiniteSteez

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

D

Answer to Question 2

C




Cooldude101

  • Member
  • Posts: 557
Reply 2 on: Jul 17, 2018
YES! Correct, THANKS for helping me on my review


flexer1n1

  • Member
  • Posts: 373
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library